HYPERION DEFI, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
HYPERION DEFI, INC. (HYPD) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-03-30
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-09-30 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-09-30 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-06-30 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2024-03-31 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2025 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2024 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2023 was 0.00%.
- HYPERION DEFI, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2022 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|---|
| 2025-12-31 | 0.00% 10-K · filed 2026-03-30 | |||
| 2025-09-30 | 0.00% 10-Q · filed 2025-11-14 | 0.00% 10-Q · filed 2025-11-14 | ||
| 2024-12-31 | 0.00% 10-K · filed 2026-03-30 | |||
| 2024-09-30 | 0.00% 10-Q · filed 2025-11-14 | 0.00% 10-Q · filed 2025-11-14 | ||
| 2024-06-30 | 0.00% 10-Q · filed 2024-08-14 | 0.00% 10-Q · filed 2024-08-14 | ||
| 2024-03-31 | 0.00% 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | 0.00% 10-K · filed 2025-04-15 | |||
| 2023-09-30 | 0.00% 10-Q · filed 2024-11-12 | |||
| 2023-06-30 | 0.00% 10-Q · filed 2024-08-14 | 0.00% 10-Q · filed 2024-08-14 | ||
| 2023-03-31 | 0.00% 10-Q · filed 2024-05-15 | |||
| 2022-12-31 | 0.00% 10-K · filed 2024-03-18 | |||
| 2022-09-30 | 0.00% 10-Q · filed 2023-11-13 | 0.00% 10-Q · filed 2023-11-13 | ||
| 2022-06-30 | 0.00% 10-Q · filed 2023-08-11 | 0.00% 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | 0.00% 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | 0.00% 10-K · filed 2023-03-31 | |||
| 2021-09-30 | 0.00% 10-Q · filed 2022-11-14 | 0.00% 10-Q · filed 2022-11-14 | ||
| 2021-06-30 | 0.00% 10-Q · filed 2022-08-11 | 0.00% 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | 0.00% 10-Q · filed 2022-05-13 | |||
| 2020-12-31 | 0.00% 10-K · filed 2022-03-30 | |||
| 2020-09-30 | 0.00% 10-Q · filed 2021-11-12 | 0.00% 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | 0.00% 10-Q · filed 2021-08-12 | 0.00% 10-Q · filed 2021-08-12 | ||
| 2020-03-31 | 0.00% 10-Q · filed 2021-05-14 | |||
| 2019-12-31 | 0.00% 10-K · filed 2021-03-30 | |||
| 2019-09-30 | 0.00% 10-Q · filed 2020-11-12 | 0.00% 10-Q · filed 2020-11-12 | ||
| 2019-06-30 | 0.00% 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | 0.00% 10-Q · filed 2020-05-14 | |||
| 2018-12-31 | 0.00% 10-K · filed 2020-03-30 | |||
| 2018-09-30 | 0.00% 10-Q · filed 2019-11-13 | 0.00% 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | 0.00% 10-Q · filed 2019-08-13 | 0.00% 10-Q · filed 2019-08-13 | ||
| 2018-03-31 | 0.00% 10-Q · filed 2019-05-14 | |||
| 2017-12-31 | 0.00% 10-K · filed 2019-03-27 | |||
| 2017-09-30 | 0.00% 10-Q · filed 2018-11-13 | 0.00% 10-Q · filed 2018-11-13 | ||
| 2016-12-31 | 0.00% 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |